369 related articles for article (PubMed ID: 17592364)
1. Omeprazole for gastroesophageal reflux disease in the first 2 years of life: a dose-finding study with dual-channel pH monitoring.
Bishop J; Furman M; Thomson M
J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):50-5. PubMed ID: 17592364
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of orally administered omeprazole in children. International Pediatric Omeprazole Pharmacokinetic Group.
Andersson T; Hassall E; Lundborg P; Shepherd R; Radke M; Marcon M; Dalväg A; Martin S; Behrens R; Koletzko S; Becker M; Drouin E; Göthberg G
Am J Gastroenterol; 2000 Nov; 95(11):3101-6. PubMed ID: 11095324
[TBL] [Abstract][Full Text] [Related]
3. 24-hour esophageal pH monitoring in children with pathological acid gastroesophageal reflux: primary and secondary to food allergy. Part I. Intraesophageal pH values in distal channel; preliminary study and control studies--after 1, 2, 4 and 9 years of clinical observation as well as dietary and pharmacological treatment.
Semeniuk J; Kaczmarski M
Adv Med Sci; 2007; 52():199-205. PubMed ID: 18217419
[TBL] [Abstract][Full Text] [Related]
4. Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy.
Leite LP; Johnston BT; Just RJ; Castell DO
Am J Gastroenterol; 1996 Aug; 91(8):1527-31. PubMed ID: 8759655
[TBL] [Abstract][Full Text] [Related]
5. 24-hour esophageal pH monitoring in children with pathological acid gastroesophageal reflux: primary and secondary to food allergy. Part II. Intraesophageal pH values in proximal channel; preliminary study and control studies--after 1, 2, 4 and 9 years of clinical observation as well as dietary and pharmacological treatment.
Semeniuk J; Kaczmarski M
Adv Med Sci; 2007; 52():206-12. PubMed ID: 18217420
[TBL] [Abstract][Full Text] [Related]
6. [Gastric acid suppression of a new oral powder omeprazole suspension for infants with gastroesophageal reflux disease. A pilot study].
Orsi M; Donato G; Busoni V; Naisberg G; Caruso N
Acta Gastroenterol Latinoam; 2011 Jun; 41(2):111-8. PubMed ID: 21894724
[TBL] [Abstract][Full Text] [Related]
7. Acid suppression does not change respiratory symptoms in children with asthma and gastro-oesophageal reflux disease.
Størdal K; Johannesdottir GB; Bentsen BS; Knudsen PK; Carlsen KC; Closs O; Handeland M; Holm HK; Sandvik L
Arch Dis Child; 2005 Sep; 90(9):956-60. PubMed ID: 16113133
[TBL] [Abstract][Full Text] [Related]
8. A comparative pharmacodynamic study of IY-81149 versus omeprazole in patients with gastroesophageal reflux disease.
Periclou AP; Goldwater R; Lee SM; Park DW; Kim DY; Cho KD; Boileau F; Jung WT
Clin Pharmacol Ther; 2000 Sep; 68(3):304-11. PubMed ID: 11014412
[TBL] [Abstract][Full Text] [Related]
9. [Role of 24 hour intraesophageal pH monitoring in diagnosis of gastroesophageal reflux and assessment of drug effectiveness].
Abidin ZU; Ivashkin VT; Sheptulin AA; Trukhmanov AS; Okhlobystin AV
Klin Med (Mosk); 1999; 77(7):39-42. PubMed ID: 10483164
[TBL] [Abstract][Full Text] [Related]
10. Frequency of gastroesophageal reflux disease in nonatopic children with asthma-like airway disease.
Yüksel H; Yilmaz O; Kirmaz C; Aydoğdu S; Kasirga E
Respir Med; 2006 Mar; 100(3):393-8. PubMed ID: 16099150
[TBL] [Abstract][Full Text] [Related]
11. [Omeprazole of limited value in crying babies].
Blokpoel RG; Broos N; de Jong-van den Berg LT; de Vries TW
Ned Tijdschr Geneeskd; 2010; 154():A1850. PubMed ID: 20719016
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of lansoprazole in children 13 to 24 months old with gastroesophageal reflux disease.
Heyman MB; Zhang W; Huang B; Chiu YL; Amer F; Winter HS
J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):35-40. PubMed ID: 17204950
[TBL] [Abstract][Full Text] [Related]
13. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux.
Omari TI; Haslam RR; Lundborg P; Davidson GP
J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):41-4. PubMed ID: 17204951
[TBL] [Abstract][Full Text] [Related]
14. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A
Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
[TBL] [Abstract][Full Text] [Related]
15. Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study.
Wo JM; Grist WJ; Gussack G; Delgaudio JM; Waring JP
Am J Gastroenterol; 1997 Dec; 92(12):2160-5. PubMed ID: 9399745
[TBL] [Abstract][Full Text] [Related]
16. Stability of gastric secretory inhibition during 6-month treatment with omeprazole in patients with gastroesophageal reflux disease.
Tefera S; Hatlebakk JG; Berstad A
Am J Gastroenterol; 2001 Apr; 96(4):969-74. PubMed ID: 11316213
[TBL] [Abstract][Full Text] [Related]
17. Empiric therapy for gastroesophageal reflux disease.
Schindlbeck NE; Klauser AG; Voderholzer WA; Müller-Lissner SA
Arch Intern Med; 1995 Sep; 155(16):1808-12. PubMed ID: 7654116
[TBL] [Abstract][Full Text] [Related]
18. Omeprazole reduces the response to capsaicin but not to methacholine in asthmatic patients with proximal reflux.
Ferrari M; Benini L; Brotto E; Locatelli F; De Iorio F; Bonella F; Tacchella N; Corradini G; Lo Cascio V; Vantini I
Scand J Gastroenterol; 2007 Mar; 42(3):299-307. PubMed ID: 17354108
[TBL] [Abstract][Full Text] [Related]
19. Treatment of oesophageal bile reflux in children: the results of a prospective study with omeprazole.
Orel R; Brecelj J; Homan M; Heuschkel R
J Pediatr Gastroenterol Nutr; 2006 Apr; 42(4):376-83. PubMed ID: 16641575
[TBL] [Abstract][Full Text] [Related]
20. Does simultaneous gastric and esophageal pH monitoring increase the diagnosis of gastroesophageal reflux disease?
Demir H; Ozen H; Koçak N; Saltik-Temizel IN; Gürakan F
Turk J Pediatr; 2005; 47(1):14-6. PubMed ID: 15884623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
